ABSTRACT 5-Hydroxytryptamine (serotonin; 5-HT) 2 receptor agonists such as (Ϯ)-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) injected systemically or directly into frontal cortex, elicit stereotyped head movements that are mediated by 5-HT 2A receptors. Chronic administration of 5-HT 2A receptor antagonists can produce either a down-regulation, e.g., d-2-bromolysergic acid diethylamide (BOL) or an up-regulation, e.g., ␣-phenyl-10(2-phenylethyl)-4-piperidinemethanol (MDL11,939) of cortical 5-HT 2A receptors in the rabbit with no change in the density of the 5-HT 2C receptor. We examined the degree to which the time course for the onset and offset of changes in cortical 5-HT 2A receptor density was correlated with functional changes as measured by the magnitude of DOI elicited, 5-HT 2A receptor-mediated head movements (head bobs). First, the magnitude of DOI-elicited head bobs was measured over 1 to 8 days after chronic BOL (5.8 mol/kg), MDL11,939 (10 mol/ kg), or vehicle administration. Second, rabbits were injected with BOL, MDL11,939, or vehicle once daily for 8 days, and then, 1 to 8 days after the cessation of drug or vehicle, DOIelicited head bobs were determined. Samples of frontal cortex were obtained for each animal immediately following behavioral testing, and 5-HT 2A receptor density was measured using [ 3 H]ketanserin. Thus, each animal provided a value for receptor density and number of head bobs, and these two measures showed a high degree of correlation between 0.94 for BOL and 0.95 for MDL11,939. This study establishes that the density of 5-HT 2A receptors in cortex reflects their functional status.
magnitude of DOI-elicited head bobs was measured over 1 to 8 days after chronic BOL (5.8 mol/kg), MDL11,939 (10 mol/ kg), or vehicle administration. Second, rabbits were injected with BOL, MDL11,939, or vehicle once daily for 8 days, and then, 1 to 8 days after the cessation of drug or vehicle, DOIelicited head bobs were determined. Samples of frontal cortex were obtained for each animal immediately following behavioral testing, and 5-HT 2A receptor density was measured using [ 3 H]ketanserin. Thus, each animal provided a value for receptor density and number of head bobs, and these two measures showed a high degree of correlation between 0.94 for BOL and 0.95 for MDL11,939. This study establishes that the density of 5-HT 2A receptors in cortex reflects their functional status.
Perturbations in neurotransmission can lead to adaptations at the receptor level, resulting in a change in the functional status of an organism. These adaptations may include changes in receptor density and/or the receptor's interaction with its cognate second messenger system. For G proteincoupled receptors, chronic activation with agonists produces down-regulation of the receptor, whereas inactivation with antagonists results in up-regulation. Studies investigating the in vivo regulation of the 5-HT 2A receptor have shown that the adaptive changes are different from those in other receptor systems. The expected adaptive change after chronic administration of antagonists, i.e., an increase in the density of receptors (Creese and Sibley, 1981) , was not observed. Unlike most G protein-coupled receptors (Tsao and von Zastrow, 2000) , numerous studies demonstrated that chronic treatment with 5-HT 2A/2C antagonists down-regulated 5-HT 2A receptor density (for reviews see Roth et al., 1998; Gray and Roth, 2001 ). However, recently, up-regulation of cortical 5-HT 2A receptors has been reported for two 5-HT 2A antagonists, SR 46349B in the rodent (Rinaldi-Carmena et al., 1993a,b) and MDL11,939 in the rabbit (Aloyo et al., 2001) . Although the mechanisms underlying 5-HT 2A receptor up-or down-regulation by antagonists are unknown, parallel changes in receptor-mediated behaviors have been demonstrated, suggesting changes in the number of coupled receptors. For example, in both the rodent and rabbit, increased density of cortical 5-HT 2A receptors was correlated with increased 5-HT 2A receptor-mediated behavior (Rinaldi-Carmona et al., 1993a,b; Aloyo et al., 2001) , whereas decreases in 5-HT 2A receptor density were correlated with decreases in 5-HT 2A receptor-mediated behavior (Blackshear and Sanders-Bush, 1982; Eison et al., 1989; Aloyo et al., 2001) . However, drug-induced alterations in receptor density could result from a change in "spare" or uncoupled receptors, resulting in no change in function. Alternatively, it has been reported that measures of receptor sensitivity rather than receptor density more accurately reflects the functional changes in behavior (Smith et al., 1990) . For example, desensitized phosphoinositide hydrolysis response to 5-HT, and not cortical 5-HT 2A receptor density, correlated with the time course for 5-HT 2A/2C receptor antagonist mianserin-elicited decrease in 5-HT 2A receptor-mediated behavior in rats. To resolve these issues, the present study systematically tested the hypothesis that 5-HT 2A receptor density in rabbit frontal cortex, as measured by radioligand binding studies, will predict their functional status as measured by 5-HT 2A receptormediated behavior.
Previous studies have demonstrated that systemic administration of the 5-HT 2A/2C receptor agonist (Ϯ)-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) elicits head bobs and body shakes in the rabbit (Dave et al., 2002b) . Moreover, the DOI-elicited head bobs have been shown to be mediated by 5-HT 2A receptors, whereas body shakes are mediated by 5-HT 2C receptor activation (Dave et al., 2002b) . The effects of DOI in the rabbit differ from those in the rodent where the 5-HT 2A receptor mediates both head twitches and body shakes (Schreiber et al., 1995; Wettstein et al., 1999) . However, in both the rodent and rabbit, 5-HT 2A -mediated motor responses to DOI are due to activation of central 5-HT 2A receptors (Willins and Meltzer, 1997; Ciccocioppo et al., 1999; Dave et al., 2004a,b) . The 5-HT 2A receptors located in the frontal cortex of the rodent (Willins and Meltzer, 1997; Ciccocioppo et al., 1999) or rabbit (see present study) seem to be especially important in mediating 5-HT 2A receptor-elicited motor responses. Therefore, the present study was carried out to determine whether there was a relationship between changes in frontal cortex receptor density and function of the 5-HT 2A receptor. We used the rabbit for several reasons. First, the cortical 5-HT 2A receptors in the frontal cortex of the rabbit have been shown to have a similar pharmacological profile to that of the human (Aloyo and Harvey, 2000) . Second, chronic administration of d-2-bromolysergic acid diethylamide (BOL) and MDL11,939 alters the density of cortical 5-HT 2A receptors with no effect on 5-HT 2C receptors (Aloyo et al., 2001) . In this study, we determined whether injection of DOI into the frontal cortex of the rabbit would elicit 5-HT 2A receptor-elicited head bobs and/or 5-HT 2C receptor-elicited body shakes. Then, we examined the time course for up-and down-regulation of the 5-HT 2A receptors in frontal cortex produced by chronic administration of MDL11,939 and BOL, respectively, and the time course for changes in the number of head bobs elicited by DOI. Receptor density and behavior were obtained from the same animal to determine the degree of correlation between these two measures.
Materials and Methods
Animals. Adult male New Zealand albino rabbits (Covance, Denver, PA), weighing 1.6 to 1.8 kg upon arrival, were housed individually under a 12/12-h light/dark cycle with access to 125 g of chow per day and free access to water in an Association for Assessment and Accreditation of Laboratory Animal Care-approved animal facility maintained at 22°C. Rabbits were adapted to their home cages for 5 days, and they were handled for at least 2 days before the initiation of experiments. All animal experiments were carried out in accordance with the Institute of Laboratory Animal Resources (1996), and they were approved by our Institutional Animal Care and Use Committee.
Drugs. BOL hydrogen tartrate was a gift from National Institute of Drug Abuse (Bethesda, MD). MDL11,939 was purchased from Tocris Cookson Inc. (Ellisville, MO), DOI hydrochloride was purchased from Sigma-RBI (St. Louis, MO), and [ 3 H]3-(2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione (ketanserin) (specific activity 88.0 Ci/mmol) was purchased from PerkinElmer Life and Analytical Sciences (Boston, MA). All drugs were prepared fresh on the day of the experiment.
Cannulae and Surgery for Intracranial Administration of DOI. The 22-gauge guide cannulae, 28-gauge obturators, and 28-gauge injector cannulae were prepared as described previously (Dave et al., 2004a) . The obturator was prepared to fit flush with the tip of the guide cannula, and the injector cannula was calibrated to extend 1 mm beyond the tip. The guide cannula/obturator assemblies were implanted under pentobarbital anesthesia using a Kopf stereotaxic apparatus (David Kopf Instruments, Tujunga, CA). The head-holder was adjusted so that the surface of the skull at bregma was 1.5 mm above the surface of the skull at lambda. Bilateral implantation coordinates for medial prefrontal cortex were 5 mm anterior to bregma, 4 mm below the surface of the skull at bregma, and 0.75 mm to each side of the midline. The cannulae were cemented with dental acrylic to two screws drilled into the skull. Rabbits were given at least 4 days to recover from surgery before initiating the behavioral experiments. After the completion of experiments, animals were sacrificed by decapitation, and brains were removed and frozen. Frozen brains were placed in a cryostat, and 25-m coronal sections were cut and thaw-mounted onto glass slides, and these sections were used to verify placements into the medial prefrontal cortex Procedures. For central infusions, DOI was dissolved in sterile, artificial cerebrospinal (aCSF) fluid containing 147 mM NaCl, 2.3 mM CaCl 2 , 0.9 mM MgCl 2 , and 4.0 mM KCl (adjusted to pH 7.3-7.4). DOI (3.0 or 10 nmol/side) and aCSF were infused bilaterally into the medial prefrontal cortex in a total volume of 1 l delivered over 1 min by a CMA/100 microinjection pump (Carnegie Medicin, Stockholm, Sweden). The injector cannula was left in place for an additional 1 min before being removed, at which time the rabbit was placed back in its home cage for a 60-min behavioral observation period. These doses of DOI were selected from previous studies demonstrating its behavioral effects in the frontal cortex of the rat (Willins and Meltzer, 1997) . For acute systemic injections, DOI (0.3 mol/kg) was dissolved in sterile saline, BOL (0.5 or 5.0 mol/kg) was dissolved in sterile deionized water, and MDL11,939 (0.1 or 1.0 mol/kg) was dissolved in sterile deionized water, acidified with acetic acid (final pH 6.4). For systemic experiments, doses of DOI were selected based upon the dose-response experiments published previously in Dave et al. (2002b) . Drugs were injected s.c. between the scapulae in a volume of 1 ml/kg. BOL or its vehicle was injected 15 min before DOI, and MDL11,939 or its vehicle was injected 60 min before DOI. Animals were placed in their home cages immediately after the DOI injection for a 90-min behavioral observation period. The pretreatment time of 15 min for BOL was chosen based upon earlier reports of its short half-life (30 min) in rat brain (Sloviter et al., 1980) and on previous behavioral studies demonstrating that BOL was ineffective in antagonizing the effects of lysergic acid diethylamide when given 60 min before testing (Kuhn et al., 1978; Colpaert et al., 1982) . To verify this in the rabbit, separate groups of animals were acutely pretreated with either BOL (5.8 mol/kg) or vehicle 3 h before challenging with DOI (0.3 mol/kg). For chronic drug administration, MDL11,939 (10 mol/kg) or its vehicle and BOL (5.8 mol/kg) or its vehicle were injected s.c. for 8 days. These doses were based on previous studies of chronic drug injection in the rabbit (Aloyo et al., 90-min behavioral observation period, after which they were euthanized, and the brains were obtained for ligand binding studies. The same procedure was used for the chronic injections of BOL and its vehicle, except that separate groups of rabbits were injected with DOI (0.3 mol/kg) 24 h after the first, third, fifth, and eighth injection and 1, 3, 5, and 8 days after the last (eighth) injection (Tables 1  and 2 illustrating the timeline of chronic injections, DOI challenge, and tissue collection). Thus, each animal provided data as to the density and functional activity of the 5-HT 2A receptor during and after chronic MDL11,939 and BOL administration, and this allowed for a determination of the correlation between these two measures.
Behavioral Observations. The observation and rating of DOI elicited behaviors have been described previously (Dave et al., 2002b) . Briefly, the number of 5-HT 2A receptor-mediated head bobs (rapid sequential "down-up" movements of the head) and 5-HT 2C receptor-mediated body shakes (a paroxysmal shudder of the head, neck, and trunk combined, similar to wet dog shakes in rodents) were video taped immediately after DOI injection, and they were subsequently counted in 10-min blocks by two independent observers (see Dave et al., 2002b for further details). Food and water were removed immediately before DOI administration. All observations took place in the animal's home cage between 9:00 AM and 3:00 PM.
Radioligand Binding Assays. The analysis of 5-HT 2A receptors using the 5-HT 2A receptor antagonist [
3 H]ketanserin has been described previously (Aloyo et al., 2001 ). Briefly, a washed membrane fraction was prepared from frozen tissue. Membrane aliquots were incubated in eight concentrations of [ 3 H]ketanserin (0.04 -3.6 nM) in 20 mM Tris-HCl, pH 7.4, at 20°C containing 30 nM RS 102221 and 30 nM 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hydrochloride (prazosin) to prevent binding to 5-HT 2C receptors and ␣ 1 -adrenoceptors, respectively. After a 2-h incubation at 25°C, bound and free ligand were separated by rapid filtration through Whatman GF/B filters (Whatman, Maidstone, UK) followed by three washes with ice-cold buffer. The amount of radioactivity retained on the filter was determined using a liquid scintillation counter, and the data were analyzed using the nonlinear curve-fitting program LIGAND (Munson and Rodbard, 1980) , which calculates K d (affinity) and B max (density) values Statistics. In acute experiments using central or systemic drug injections, the total number of 5-HT 2A -mediated head bobs and 5-HT 2C -mediated body shakes were subjected to a one-way analysis of variance with the main effect of drug treatment. Post hoc analyses were performed using Dunnett's t test with the limit of significance set at p Ͻ 0.05. For experiments using chronic drug administration, animals treated chronically with vehicle at each time point were compared with each other by one-way analysis of variance for differences in DOI-induced head bobs as well as receptor density. When there were no differences observed across different vehicle-treated time groups (p Ͼ 0.1), the average means were collapsed across time. The drug-treated groups were compared with the collapsed vehicle group, and data were subjected to a one-way analysis of variance. Post hoc analyses were performed using Tukey's test for multiple comparison between treatment days, with the limit of significance set at p Ͻ 0.05. Finally, the Pearson product moment coefficient of correlation (Hays, 1981; Aloyo and Harvey, 2000) was used to test the degree of association between the density of 5-HT 2A receptors in the frontal cortex and their functional status as measured by the number of 5-HT 2A receptor-mediated head bobs elicited by DOI.
Results
Intracortical Administration of DOI. As shown in Fig.  1 , injection of DOI into the medial prefrontal cortex produced a significant, dose-dependent increase in head bobs [F(2, 6) ϭ 8.38; p Ͻ 0.05]. Animals receiving injection of aCSF exhibited 9.6 Ϯ 0.8 head bobs and 1.0 Ϯ 0.5 body shakes during the 1-h observation period. Intracortical DOI significantly increased the number of 5-HT 2A receptor-mediated head bobs to 24.3 Ϯ 6.9 (3.0 nmol/side) and 45.3 Ϯ 8.1 (10 nmol/side), respectively. In contrast, intracortical DOI had no significant or consistent effect on the frequency of 5-HT 2C receptor-mediated body shakes. Similarly, injections of DOI into the lateral ventricles (i.c.v.) also failed to elicit body shakes in the rabbit (Dave et al., 2004b) , indicating that the frontal cortex is not a critical locus for 5-HT 2C receptor-mediated body shakes. However, i.c.v. administrations produced dose-dependent head bobs that were blocked by 5-HT 2A antagonist ketanserin (Dave et al., 2004b) . Based on these and previous findings (Aloyo et al., 2001; Harvey et al., 2004) Sac a Sac, DOI administration and behavioral observation for 90 min immediately followed by collection of frontal cortex. (Fig. 3A) . The number of head bobs produced by DOI was significantly reduced by 1-h pretreatment with MDL11,939 at both the 0.1 mol/kg s.c., (23.3 Ϯ 1.7) and 1.0 mol/kg s.c. doses (8.8 Ϯ 1.2) [F(2, 15) ϭ 43.9; p Ͻ 0.05]. In a separate experiment (Fig. 3B) , DOI (0.3 mol/kg s.c.) elicited 35.3 Ϯ 3.4 head bobs. BOL given 15 min before DOI treatment significantly decreased the number of head bobs at both 0.5 mol/kg (10.6 Ϯ 2.8) and 5.0 mol/kg (8.0 Ϯ 2.5), respectively [F(2, 7) ϭ 6; p Ͻ 0.05]. However, in agreement with previous reports of its short half-life (Sloviter et al., 1980) , BOL (5.8 mol/kg) failed to block DOIelicited head bobs when given 3 h before DOI (Fig. 3C) . Thus, both MDL11,939 and BOL were effective antagonists of 5-HT 2A receptor-mediated head bobs elicited by DOI when given at 1 h and 15 min, respectively. (Fig. 4A) . Repeated injections of the vehicle had no significant effect on DOI-elicited head bobs, the mean value across all injection days being 15.1 Ϯ 0.56 (n ϭ 16). A significant, 40% increase in head bobs above vehicle control, occurred 24 h after the first injection, and it reached 85% above controls after the eighth injection. The number of DOI-elicited head bobs remained significantly higher than controls for 4 days after the last (eighth) injection of MDL11,939 [F(4, 27) ϭ 30; p Ͻ 0.05] (Fig. 4B) . Vehicle controls showed no significant change in the number of DOI-elicited head bobs over this 8-day period, the mean number of head bobs being 14.2 Ϯ 0.73 (n ϭ 16). Animals that had received chronic MDL11,939 injections returned to these control levels by day 8.
5-HT
A sample of frontal cortex was obtained from all of the animals injected with MDL11,939 or its vehicle and tested for DOI-elicited head bobs. The repeated administration of vehicle had no significant effect on 5-HT 2A receptor density in frontal cortex (Fig. 4C) , the average receptor density (B max ) in vehicle controls across days 1 to 8 being 9.16 Ϯ 0.15 fmol/mg tissue (n ϭ 16). Repeated daily injections of MDL11,939 (10 mol/kg s.c.) produced a significant increase in the number of 5-HT 2A receptors in the frontal cortex [F(4, 27) ϭ 184.6; p Ͻ 0.05]. A significant 30% increase in the density of 5-HT 2A receptors was seen 24 h after the first injection, and it reached 81% above controls after the eighth injection. The increase in cortical 5-HT 2A receptor density persisted for 4 days after cessation of MDL11,939 injections (Fig. 4D) . These increases were 73, 70, and 57% above vehicle controls values (on days 1, 2, and 4, respectively). Receptor density was significantly increased up to day 4 [F(4, 27) ϭ 200; p Ͻ 0.05], and it returned to the values for vehicle controls (9.31 Ϯ 0.15 fmol/mg tissue; n ϭ 16) some time between days 4 and 8. There were no significant differences in the K d (affinity) values in any of the groups tested (values not shown).
Chronic Parenteral Administration of BOL: Effects on 5-HT 2A Receptor Density and Function. In contrast with MDL11,939, chronic BOL (5.8 mol/kg s.c.) injections significantly reduced the number of head bobs produced by 0.3 mol/kg DOI [F(4, 27) ϭ 70; p Ͻ 0.05] (Fig. 5A ). There were no significant changes in the number of head bobs elicited by DOI in vehicle controls (37.9 Ϯ 1.5; n ϭ 8). One injection of BOL significantly decreased the number of head bobs elicited by DOI 24 h later by 30%. Subsequently, daily injections of BOL for 3, 5, or 8 days significantly decreased the number of head bobs to 19.7 Ϯ 2.1, 12 Ϯ 1.6, and 10.7 Ϯ 1.7, respectively. The significant decrease in DOI-elicited head bobs persisted for 5 days after the last (eighth) injection (Fig.  5B) .
A sample of frontal cortex was also obtained from all of the animals injected with BOL or its vehicle and tested for DOIelicited head bobs. The chronic injections of BOL resulted in a significant decrease in the density of 5-HT 2A receptors [F(4, 27) ϭ 25; p Ͻ 0.05] (Fig. 5C ). 5-HT 2A receptor density was reduced by 20% within 24 h after the first injection of BOL, with a B max value of 9.96 Ϯ 0.4 (n ϭ 8) for vehicle controls and 8.0 Ϯ 0.2 (n ϭ 4) in BOL-treated animals. At 24 h after the eighth BOL injection 5-HT 2A receptor density had been decreased by 40%. After the last (eighth) BOL injection, 5-HT 2A receptor density remained significantly below the value for vehicle controls (37.4 Ϯ 1.8; n ϭ 8) for 5 days before returning to control values by day 8 [F(4, 27) ϭ 20; p Ͻ 0.05] (Fig. 5D ). There were no significant differences in the K d (affinity) values in any of the groups tested (values not shown).
Correlation between 5-HT 2A Receptor Density and DOI-Elicited Head Bobs. Pearson product moment coefficients of correlation between 5-HT 2A receptor density and head bobs were calculated using data obtained separately from the animals of Fig. 4 given MDL11,939 or its vehicle (n ϭ 63) and the animals of Fig. 5 given BOL or its vehicle (n ϭ 48). There was a high and significant correlation between the number of 5-HT 2A receptors in the frontal cortex and elicitation of head bobs for animals given chronic injections of MDL11,939 (Fig. 6A) or BOL (Fig.  6B) . Thus, the increase and return to control levels of 5-HT 2A receptor density during and after chronic treatment with MDL11,939 and its vehicle yielded a significant Pearson product moment coefficient of correlation (r ϭ 0.95, p Ͻ 0.05) (Fig. 6A) . Similarly, there was also a highly significant correlation (r ϭ 0.94, p Ͻ 0.05) between the density and head bobs in animals treated with BOL or its vehicle (Fig. 6B ). The differences in the slopes of the regression lines shown in Fig. 6, A and B, are due to the different doses of DOI used for the MDL11,939 and BOL experiments. Based on previous results (Aloyo et al., 2001) , the chronic BOL treatment was predicted to produce a 5-HT 2A receptor down-regulation. Thus, these rabbits were injected with a high, but submaximal dose of DOI (0.3 mol/kg) to avoid a floor effect. Conversely, chronic MDL11,939 was predicted to result in 5-HT 2A receptor Twenty-four hours after the last injection, the number of head bobs following challenge with DOI (0.03 mol/kg) was counted (A). Immediately after behavioral observations, animals were sacrificed, and cortical 5-HT 2A receptor density (B max ) was determined (C). B and D, animals were injected with MDL11,939 (10 mol/kg) or its vehicle once daily for 8 days. One to 8 days after the last drug or vehicle injection, separate groups of rabbits (n ϭ 4) were injected with DOI (0.03 mol/kg), and head bobs were counted (B). Immediately after behavioral observations, animals were sacrificed and cortical 5-HT 2A receptor density (B max ) was determined (D). For MDL11,939-treated animals, each time point is the mean Ϯ S.E.M. for four animals. The mean Ϯ S.E.M. for 16 vehicle-treated animals is represented by a solid line and dashed line, respectively. The limit of significance for Tukey's multiple comparison tests between treatment days was set at p Ͻ 0.05. ‫,ء‬ different from collapsed vehicle; †, different from MDL1 and MDL2 groups; † †, different from MDLrecov1, MDLrecov2, and MDLrecov4 groups; #, different from MDLrecov1 and MDLrecov2 groups; and @, different from MDLrecov2 group. up-regulation (Aloyo et al., 2001) . Thus, animals given chronic MDL11,939 were injected with a low dose of DOI (0.03 mol/kg) to avoid a ceiling effect.

Discussion
Time Course for Development of Receptor Up-and Down-Regulation and Recovery. Previous investigations have established that 5-HT 2A receptor antagonists can either up-regulate or down-regulate the density of rabbit cortical 5-HT 2A receptors (Aloyo et al., 2001; Harvey et al., 2004) . Although chronic treatment with antagonists normally upregulate receptors (Tsao and von Zastrow, 2000) , the majority of 5-HT 2A receptor antagonists have been shown to decrease receptor density (for review, see Gray and Roth, 2001 ). To date, MDL11,939 (Aloyo et al., 2001; Harvey et al., 2004) and SR 46349B (Rinaldi-Carmona et al., 1993a,b) are the only 5-HT 2A receptor antagonists that have been demonstrated to up-regulate these receptors in vivo, but the time course for up-regulation has not been reported previously. The results of the present study indicate similar time courses for up-and down-regulation of cortical 5-HT 2A receptors as well as for their recovery to normal densities. Thus, cortical 5-HT 2A receptor density was significantly increased by MDL11,939 (30%) and decreased by BOL (20%) at 24 h after a single injection. Consistent with our previous findings (Aloyo et al., 2001; Harvey et al., 2004) , cortical 5-HT 2A receptor density had increased by 73% after MDL11,939 and decreased by 40% after BOL following eight daily injections. Cessation of drug injections revealed that the time required for the return of cortical 5-HT 2A receptor densities to control Twenty-four hours after the last injection, the number of head bobs following challenge with DOI (0.3 mol/kg) was counted (A). Immediately after behavioral observations, animals were sacrificed, and cortical 5-HT 2A receptor density (B max ) was determined (C). B and D, animals were injected with BOL (5.8 mol/kg) or its vehicle once daily for 8 days. One to 8 days after the last drug or vehicle injection, separate groups (n ϭ 4) were injected with DOI (0.3 mol/kg), and head bobs were counted (B). Immediately after behavioral observations, animals were sacrificed, and cortical 5-HT 2A receptor density (B max ) was determined (D). For BOL-treated animals, each time point is the mean Ϯ S.E.M. of four animals. The mean Ϯ S.E.M. for eight vehicle-treated animals is represented by a solid line and dashed line, respectively. The limit of significance for Tukey's multiple comparison tests between treatment days was set at p Ͻ 0.05. ‫,ء‬ different from collapsed vehicle; †, different from BOL1 and BOL3 groups; #, different from BOL3 group; @, different from BOLrecov1 and BOLrecov3 groups; and † †, different from BOLrecov1, BOLrecov3, and BOLrecov5 groups. levels was within the same range for MDL11,939 (4 -8 days) and for BOL (5-8 days). These recovery times are within the range of recoveries reported after up-regulation of D 1 receptors (5 days; Fuxe et al., 1987) , 5-HT 1A receptors (4 -7 days; Raghupati et al., 1996) , and 5-HT 2A receptors (4 to 6 days; Harvey et al., 2004) . These time courses are also in agreement with studies in which down-regulation of 5-HT 2 or 5-HT 2A receptor density returned to normal levels after 6 -10 days (Leysen and Pauwels, 1990; Kettle et al., 1999) .
Chronic BOL treatment failed to down-regulate 5-HT 2A receptors in rats (Buckholtz et al., 1990) , possibly due to the use of a lower dose of BOL (2.5 mol/kg) compared with that used in the current study (5.8 mol/kg). The high dose of BOL used in the current study raises the question of whether failure to eliminate residual drug accounts for the changes observed after a single injection of BOL. In vivo, the presence of residual BOL 24 hours later could account for the observed decrease in DOI-elicited head bobs. To test this hypothesis, DOI-elicited head bobs were examined 15 min and 3 h following BOL administration. The 15-min pretreatment significantly attenuated DOI-elicited head bobs. However, 3 h following BOL, DOI-elicited behaviors were not significantly different from saline-treated controls. These results demonstrate that within 3 h BOL is no longer behaviorally active, and they suggest the absence of residual BOL at 24 h. Similarly in vitro residual BOL might explain the decreased 5-HT 2A receptor density observed 24 h following a single injection of BOL. The presence of residual BOL in the binding assay would act as a competitive inhibitor, leading to an increased K d value and representing a decreased ketanserin binding affinity. However, only the B max (density) was reduced by in vivo BOL treatment without an increase in K d value (decreased affinity). Thus, the combination of no behavioral changes after 3 h and the observation that the affinity was not changed in the binding assays supports the argument that the behavioral desensitization observed 24 h after one injection of BOL is due to a decrease in 5-HT 2A receptor density and not simply due to residual receptor occupancy.
The rapid decrease in cortical 5-HT 2A receptor density and rapid behavioral desensitization observed in this study following repeated BOL administration is similar to the time course for down-regulation reported in rat cortical membranes following repeated administration of the 5-HT 2 antagonist 6- [2-[4-[bis(4-fluorophenyl) (Leysen et al., 1986 ) and the 5-HT 2 agonist 2,5-dimethoxy-4-methylphenylisopropylamine (Leysen et al., 1989) . Several mechanisms for 5-HT 2A down-regulation have been proposed (Roth et al., 1998) , including receptor internalization observed in vivo and in vitro (Willins et al., 1999) . It can be inferred from the slow reappearance of receptors after down-regulation that receptor internalization followed by degradation in lysosomes may be responsible for downregulation. However, it seems unlikely that transcriptional regulation significantly contributes to the antagonist induced 5-HT 2A receptor down-regulation (for review, see Gray and Roth, 2001) . For example, chronic treatments with 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepine (mianserin) (Roth and Ciaranello, 1991) (Burnet et al., 1996) , and 10,11-dihydro-N,Ndimethyl-5H-dibenz[b,f]azepine-5-propanamine (imipramine) (Burnet et al., 1994) did not significantly alter 5-HT 2A mRNA in rat cortex, even though these treatments resulted in significant receptor down-regulation.
To our knowledge, this study is the first to systematically determine the time course for antagonist induced 5-HT 2A receptor up-regulation. The current study demonstrates rapid up-regulation of receptor number along with increased receptor sensitivity following MDL11,939 treatment. The receptor up-regulation observed in this study with MDL11,939 is consistent with previous results from our laboratory (Aloyo et al., 2001; Dave et al., 2004a; Harvey et al., 2004) , and it further establishes that 5-HT 2A can be differentially regulated by 5-HT 2A antagonists. It has been proposed that receptor regulation (up-or down-) may be a function of antagonists acting as neutral antagonist or inverse agonists at the 5-HT 2A receptor (Aloyo et al., 2001; Berg et al., 2005) , although more data are required to determine how some an- jpet.aspetjournals.org tagonists down-regulate, whereas others up-regulate the 5-HT 2A receptor. Interestingly, receptor recovery after upregulation by MDL11,939 was similar (4 -6 days) to that observed for receptor recovery after down-regulation by BOL. This suggests that MDL11,939 and BOL may act by modulating the balance between the protein degradation and synthesis pathways. Indeed, we have previously reported that MDL11,9393 treatment increased 5-HT 2A receptor protein levels as measured by Western blot (Dave et al., 2002a) or immunohistochemistry (Dave et al., 2004a) in the dorsal hippocampus, suggesting effects on those pathways.
Measures of 5-HT 2A Receptor Density Accurately Reflect the Functional Status of the Receptor. The present results in the rabbit were obtained under conditions in which the density of cortical 5-HT 2A receptors (B max ) was altered with no change in its affinity (K d ), and, based on previous studies in the rabbit, with no change in the density or affinity of cortical 5-HT 2C receptors (Aloyo et al., 2001 ). Moreover, drug-induced increases and decreases in 5-HT 2A receptor density have been reported to have no effect on the ratio of coupled to uncoupled forms of the receptor (Aloyo et al., 2001) , suggesting that the alterations in receptor density should be highly associated with receptor function. Our measure of the functional status of the 5-HT 2A receptor used the head bob response in the rabbit. The major finding of this study was that there was a high degree of association between cortical 5-HT 2A receptor density (B max ) and the elicitation of 5-HT 2A receptor-mediated head bobs. The high degree of association between these two variables (0.94 and 0.95) indicated that the functional status of the receptor could be predicted from receptor density whether the receptor was being up-regulated and then recovering as in the case of chronic MDL11,939 or whether it was being down-regulated and then recovering after chronic BOL treatment.
The high degree of correlation between 5-HT 2A receptormediated behavior and cortical 5-HT 2A receptor density suggests that the frontal cortex is involved in mediating head bob behavior. In other species, direct cortical administration of the 5-HT 2A/2C receptor agonists DOI and (Ϯ)-2,5-dimethoxy-4-bromoamphetamine have been shown to dose-dependently elicit head shakes and wet dog shakes in rats (Ciccocioppo et al., 1999) and head twitches in mice (Willins and Meltzer, 1997) . Likewise, direct administration into the rabbit medial prefrontal cortex of 5-HT 2A/2C receptor agonist DOI elicited dose-dependent increases in the number of head bobs. Hence, similar to the rodent, 5-HT 2A receptors in the rabbit frontal cortex activate neuronal circuitry to subsequently modulate motor behavior. The head bob is an observational response indicating enhanced attention to and localization of arousing environmental stimuli. Such arousal can also lead to increased exploratory behavior in the rabbit (Bland et al., 1984) , and it has been correlated with increased activity of cortical neurons in the rabbit (Fontani et al., 1984) . Indeed, agonists at the 5-HT 2A receptor have been shown to increase the firing of cortical neurons, increase prefrontal cortical metabolism, increase cortical glutamate release, increase cortical c-fos expression, and produce behavioral arousal (for a full review, see Nichols, 2004) . These results confirm the role of the prefrontal cortex as a site of action for 5-HT 2A receptor agonists to induce behavioral responses.
In summary, the results of this study suggest that 5-HT 2A receptor antagonists can evoke unique mechanisms that produce either up-or down-regulation of receptor number. These changes are predictive of changes in receptor-mediated behaviors. The identical time course of these changes suggests a common mechanism that normally regulates the balance between receptor internalization and externalization that can be observed as soon as 24 h after drug injection. Our further understanding of these mechanisms may provide insights into central nervous dysfunctions and their therapeutic treatment.
